Search results for "colon cancer"

showing 10 items of 157 documents

Antiproliferative effects of bioaccessible fractions of honeys from Sicilian black honeybee (Apis mellifera ssp. sicula) on human colorectal carcinom…

2021

The aim of this study was to evaluate the antiproliferative activity of bioaccessible fractions (BFs) obtained by the internationally standardized INFOGEST static digestion method to Sicilian honeys of three distinct floral origins (Sulla, Thistle and Dill) and the Manuka honey (gold standard), and to compare their effects based on total polyphenol content (TPC). Differentiated CaCo-2 cells (intestinal-like) and non-differentiated CaCo-2 and HCT-116 colonic tumour-like cells were incubated for 24 h with BFs of honeys to test viability, apoptosis, mitochondrial membrane potential (MMP), ROS and cell cycle. TPC after digestion ranked in the following order: Dill > Thistle > Sulla > M…

Traditional medicinein vitro digestionChemistryColorectal cancerhoneyIn vitro digestionmedicine.diseaseIndustrial and Manufacturing Engineeringlanguage.human_languagecolon cancerPolyphenolSettore BIO/10 - BiochimicalanguagemedicineSicilianAntiproliferative effectspolyphenolsFood Science
researchProduct

Rôles des cellules myéloïdes suppressives et des infiltrats immunitaires dans le cancer

2013

Immune system plays a dual role in cancer: it can not only suppress tumor growth by destroying cancer cells, but also promote tumor progression by selecting immunoresistant tumor cells or by establishing an immunosuppressive microenvironment. Our main objective is to foster on the context of immune response in colon cancer settingDuring my thesis, I focused on one population of the immunosuppressive cells immune system: MDSC (myeloid derived suppressor cells). In this work, we explored strategies to reduce the number of these cells during tumor growth. We have discovered that small doses of 5 Fluorouracil are able to specifically induce apoptotic death of MDSC. We have characterized a novel…

Treg[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyImmunosurveillanceMDSCCancer coliqueCD8Colon cancer
researchProduct

Tributyltin(Iv) butyrate: A novel epigenetic modifier with er stress-and apoptosis-inducing properties in colon cancer cells

2021

Organotin(IV) compounds are a class of non-platinum metallo-conjugates exhibiting antitumor activity. The effects of different organotin types has been related to several mechanisms, including their ability to modify acetylation protein status and to promote apoptosis. Here, we focus on triorganotin(IV) complexes of butyric acid, a well-known HDAC inhibitor with antitumor properties. The conjugated compounds were synthesized and characterised by FTIR spectroscopy, multi-nuclear (1H, 13C and 119Sn) NMR, and mass spectrometry (ESI-MS). In the triorganotin(IV) complexes, an anionic monodentate butyrate ligand was observed, which coordinated the tin atom on a tetra-coordinated, monomeric enviro…

Triorganotin(IV) butyratesPharmaceutical ScienceOrganic chemistryApoptosisButyrateArticleHistone DeacetylasesAnalytical ChemistryEpigenesis GeneticButyric acidchemistry.chemical_compoundQD241-441HDAC inhibitorsCell Line TumorSettore BIO/10 - BiochimicaDrug DiscoveryHumansPhysical and Theoretical ChemistrybiologyAcetylationLigand (biochemistry)Endoplasmic Reticulum StressColon cancerHistonechemistryBiochemistryHistone acetylationChemistry (miscellaneous)ApoptosisAcetylationSettore CHIM/03 - Chimica Generale E InorganicaColonic NeoplasmsTributyltinbiology.proteinUnfolded protein responseMolecular MedicineButyric AcidTrialkyltin CompoundsER stressProtein Processing Post-Translational
researchProduct

Carob leaves polyphenols trigger intrinsic apoptosis pathway and induce cell cycle arrest in colon cancer cells

2016

IF 4.066; International audience

[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]PolyphenolsColon cancer
researchProduct

Etude des mécanismes d'action d'une immunothérapie par un lipide A, seul ou associé à l'oxaliplatine, dans des modèles de cancers coliques

2013

Colorectal cancer is a major public health concern in France. Resistance to standard chemotherapy requires development of novel therapeutic approaches. In the past decades, our team showed the immunotherapeutic properties of lipid A in a model of colon cancer in rats. 95% of rats bearing small carcinomas were cured following treatment by lipid A. The study of mechanisms underlying this immunotherapy allowed us to show that the antitumor effect of lipid A was dependent on cytotoxicity induced by granzyme B produced by intratumoral neutrophils. Indeed, we have shown that, in the tumor microenvironment, neutrophils produced granzyme B and had a pro-tumorigenic N2 phenotype. When rats were trea…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyNeutrophilsGranzyme BImmunothérapieNeutrophilesColon cancerLipide AOxaliplatinLipid A[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyCancer coliqueImmunotherapySénescenceOxaliplatine[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Goodness-of-fit tests for parametric excess hazard rate models with covariates

2017

In this paper we propose a general methodology for testing the null hypothesis that an excess hazard rate model, with or without covariates, belongs to a parametric family. Estimating the excess hazard rate function parametrically through the maximum likelihood method and non-parametrically (or semi-parametrically) we build a discrepancy process which is shown to be asymptotically Gaussian under the null hypothesis. Based on this result we are able to build some statistical tests in order to decide wether or not the null hypothesis is acceptable. We illustrate our results by the construction of chi-square tests which the behavior is studied through a Monte-Carlo study. Then the testing proc…

[STAT]Statistics [stat]Proportional excess hazards modelSemiparametric estimation[ STAT ] Statistics [stat]Maximum likelihood estimationNonparametric estimationcolon cancer dataCovariatesExcess hazard model[STAT] Statistics [stat]
researchProduct

Retrospektīvs pētījums par dzīvildzi resnās zarnas vēža II stadijā, atkarībā no ārstēšanas stratēģijas

2017

Ievads: Adjuvanta ķīmijterapija pacientiem ar diagnosticētu II (UICC) stadijas resnās zarnas vēzi ir apsverama. Pacientu dalījums augsta un zema riska grupās, palīdz izlemt, vai pēc ķirurģiskas ārstēšanas ir indicēta ķīmijterapija, lai gan dzīvildzes ieguvumi nav ne plaši pētīti, nedz arī pierādīti. Tāpēc, autora mērķis šajā pētījumā bija salīdzināt piecu gadu dzīvildzi UICC II stadijas resnās zarnas vēža pacientiem, kuri saņēma adjuvantu ķīmijterapiju, un pacientiem, kuri ķīmijterapiju nesaņēma. Metodes: Dati par pacientiem ar II stadijas resnās zarnas vēzi, tika iegūti Paula Stradiņa Klīniskās universitātes slimnīcā Rīgā, Latvijā, Onkoloģijas klīnikā. Diagnozes apstiprināšanas laiks no 20…

adjuvant chemotherapycolon cancer stage IIUICC IIoverall five-year survivalMedicīna
researchProduct

Ethanol promotes survival and tumor progression of colon cancer cells

2018

In the Western Countries, colon cancer is the third tumor for aggressiveness and incidence after lung and breast/prostate cancer. Different risk factors concur to the development of colon cancer, including genetic factors, inflammation, intestinal microflora composition, as well as lifestyle. Epidemiologic studies correlating alcohol consumption and assert that the risks are 5-fold higher among drinkers compared to nondrinkers. However, the exact mechanisms correlating heavy alcohol drinking and colon cancer are not completely elucidated yet. To shed light on the biochemical mechanisms through which alcohol favors colon cancer progression, we evaluated the effect of high doses of ethanol (1…

autophagySettore BIO/10 - BiochimicaMMPsEthanol colon cancer Nrf2 HO1 ER stre
researchProduct

Three New Medicagenic Acid Saponins from Polygala micranthaGuill. & Perr.

2011

Three new medicagenic acid saponins, micranthosides A–C (1–3), were isolated from the roots of Polygala micranthaGuill. & Perr., along with six known presenegenin saponins. Their structures were elucidated on the basis of extensive 1D- and 2D-NMR experiments (1H, 13C, DEPT, COSY, TOCSY, NOESY, HSQC, and HMBC) and mass spectrometry as 3-O-β-D-glucopyranosylmedicagenic acid 28-[O-β-D-galactopyranosyl-(14)-O-β-D-xylopyranosyl-(14)-O-α-L-rhamnopyranosyl-(12)-β-D-fucopyranosyl] ester (1), 3-O-β-D-glucopyranosylmedicagenic acid 28-[O-6-O-acetyl-β-D-galactopyranosyl-(14)-O-β-D-xylopyranosyl-(14)-O-α-L-rhamnopyranosyl-(12)-β-D-fucopyranosyl] ester (2), and 3-O-{O-β-D-glucopyranosyl-(13)-O-[β-D-gluc…

biologyChemistryStereochemistryOrganic ChemistryDEPTMass spectrometrybiology.organism_classificationBiochemistryCatalysisPolygalaMedicagenic acidInorganic ChemistryHuman colon cancerDrug DiscoveryPhysical and Theoretical ChemistryCytotoxicityTwo-dimensional nuclear magnetic resonance spectroscopyHeteronuclear single quantum coherence spectroscopyHelvetica Chimica Acta
researchProduct

EFFICACY OF ZOLEDRONIC ACID IN PATIENTS WITH COLORECTAL CANCER METASTATIC TO BONE

2010

Introduction. Bone metastases are an emerging clinical problem in colorectal cancer patients probably related to survival increase. There are no data in literature about the role of BPs in the treatment of bone disease from colorectal cancer. We present the final data of a large Italian multicenter retrospective analysis. Methods. 264 colorectal cancer patients with occurrence of bone metastases have been included in the study. All patients were dead due to cancer at the moment of the study inclusion. Patients characteristics, Skeletal Related Events (SRE) data and median survival after bone metastases appearance have been collected in a master data base and statistically analyzed. The prim…

bone metastasis metastatic colon cancerSettore MED/06 - Oncologia Medica
researchProduct